🟢 Immunitybio is trading 4.5% up today as U.S. equities advance

Immunitybio is trading 4.54% up now at $8.62 as U.S. equities advance.

• The Nasdaq Composite is up 1.38%, while the S&P 500 is up 0.64%.
• No fresh company-specific announcement dated August 27, 2026, was identified.
• Recent quarterly revenue growth, upcoming ANKTIVA regulatory milestones, and elevated trading volume remain supportive background factors, but available reporting does not directly link them to this session’s move.